Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Blog | Cardiovascular Ultrasound

I attended the American Society of Echocardiography (ASE) 2018 meeting in June and have the following takeaways on ...

Home July 10, 2018
Home
Videos | Cardiovascular Ultrasound

DAIC Editor Dave Fornell highlights some of the most innovative new technology on the show floor of the American Society ...

Home July 10, 2018
Home
Two versions of the Abiomed Impella percutaneous ventricular assist device being shown at ACC 2018. Impella is the only device currently cleared by the FDA for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia ...
Home July 08, 2018
Home
Videos | Heart Valve Technology

Rebecca Hahn, M.D., professor of medicine and director of interventional echocardiography, Columbia University Medical ...

Home July 05, 2018
Home
News | CT Angiography (CTA)

July 3, 2018 — HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access ...

Home July 03, 2018
Home
News | Peripheral Artery Disease (PAD)

July 2, 2018 — The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long ...

Home July 02, 2018
Home
Videos | Cardiovascular Ultrasound

This is a demonstration of the the Philips TrueVue photo-realistic rendering and lighting source technology. This ...

Home June 28, 2018
Home
News | CT Angiography (CTA)

June 25, 2018 — Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the ...

Home June 25, 2018
Home
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.
Feature | Hemodynamic Support Devices | Dave Fornell, Editor

About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients a ...

Home June 22, 2018
Home
Amaranth's Fortitute bioresorbable stent scaffold. The company is developing smaller strut BRS.  Data presented at EuroPCR 2018
Feature | Stents Bioresorbable

June 19, 2018 – Amaranth Medical offered new details about its 85-micron Defiance bioresorbable scaffold (BRS) recently ...

Home June 19, 2018
Home
Technology | Drug-Eluting Balloons

June 15, 2018 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths ...

Home June 15, 2018
Home
News | Guidewires

June 14, 2018 — The U.S. Food and Drug Administration (FDA) released the following two draft guidance documents:


Home June 14, 2018
Home
News | Heart Valve Technology

June 13, 2018 — Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to ...

Home June 13, 2018
Home
News | Magnetic Resonance Imaging (MRI)

June 8, 2018 — Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis ...

Home June 08, 2018
Home
News | Embolic Protection Devices

June 7, 2018 — The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used ...

Home June 07, 2018
Home
Subscribe Now